Relations between occurrence of the risk of food-drug interactions and patients' socio-demographic characteristics and selected nutrition habits

• Autorzy: Jarosz M. , Wolnicka K.
• Języki publikacji: EN

Abstrakty

EN

The objective of the study was to investigate the patients’ exposure to food-drug interactions, and to analyse the main factors leading to a risk of interactions in the examined patients. A high (62.4%) risk of food-drug interactions incidence, which may cause various complications in therapy, was found in the study. The majority of patients (52.8%) were not aware that the timing of drug intake in relation to meals may affect treatment. High exposure to food-drug interactions in patients results generally from their lack of awareness of such interactions and of their effects. The results of the study show that educating patients, physicians, dieticians and nurses on the impact of food on the effects of drugs is necessary to mitigate pharmacotherapy complications.

• Wydawca: -
• Czasopismo: Polish Journal of Food and Nutrition Sciences
• Rocznik: 2011
• Tom: 61
• Numer: 3
• Opis fizyczny: p.211-218,fig.,ref.

Twórcy

autor

Jarosz M.

• Department of Dietetics and Hospital Nutrition with Clinic of Metabolic Diseases and Gastroenterology, National Food and Nutrition Institute, Powsinska Str. 61/63, 02-903 Warsaw, Poland

autor

Wolnicka K.

Bibliografia

• 1. Arayne M.S., Sultana N., Bibi Z., Grapefruit juice-drug interactions. Pak. J. Pharm. Sci., 2005, 18, 4, 45–57.
• 2. Bailey D.G., Dresser G.K., Grapefruit juice-lovastatin interaction. Clin. Pharmacol. Ther., 2000, 67, 690.
• 3. Boullata J.I., Armenti V.T. eds. Handbook of Drug-Nutrient Interactions. 2004, Humana Press, New Jersey, pp. 3–515.
• 4. Bressler R., Grapefruit juice and prescription drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs. Geriatrics, 2006, 61, 12–18.
• 5. Conner K.G., Drug-nutrient interactions. 2005, in: Encyclopedia of Human Nutrition. vol 2. (eds. B. Coballero, L. Allen, A. Prentice). Elsevier Press, Oxford, pp. 1904–1912.
• 6. Couris R.R., Tataronis G.R., Dallal G.E., Blumberg J.B., Dwyer J.T., Assessment of healthcare professionals’ knowledge about warfarin-vitamin K drug-nutrient interactions. J. Am. Coll. Nutr., 2000, 19, 439–445.
• 7. Dresser G.K., Spence J.D., Bailey D.G., Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin. Pharmacokinet., 2000, 38, 41–57.
• 8. Fraga Fuentes M.D., Garcia Diaz B., de Juana Velasco P., Bermejo Vicedo M.T., Influence of foods on the absorption of antimicrobial agents. Nutr. Hosp. 1997, 12, 277–288 (in Spanish; English abstract).
• 9. Fulton M.M., Allen E.R., Polypharmacy in the elderly: a literature review. J. Am. Acad. Nurse Pract., 2005, 17, 123–132.
• 10. Gauthier I., Malone M., Lesar T.S., Aronovitch S., Comparison of programs for preventing drug-nutrient interactions in hospitalized patients. Am. J. Health. Syst. Pharm., 1997, 54, 405–411.
• 11. Genser D., Food and drug interaction: consequences for the nutrition/ health status. Ann. Nutr. Metab., 2008, 52, Suppl. 1, 29–32.
• 12. Ho P.C., Saville D.J., Wanwimolruk S., Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J. Pharm. Pharmaceut. Sci., 2001, 4, 217–227.
• 13. Jarosz M., Dzieniszewski J. eds., Interakcje leków z żywnością i alkoholem. 2004, Borgis, Warsaw, pp. 3–215 (in Polish).
• 14. Johnson B.F., Rodin S.M., Hoch K., Shekar V., The effect of dietary fiber on the bioavailability of digoxin in capsules. J. Clin. Pharmacol., 1987, 27, 487–490.
• 15. Jung H., Peregrina A.A., Rodriguez J.M., Moreno-Esparza R., The influence of coffee with milk and tea with milk on the bioavailability of tetracycline. Biopharm. Drug Dispos., 1997, 18, 459–463.
• 16. Kardas P., Ratajczyk-Pakalska E., Not adhering to the medical recommendations – medical and social problem. Gerontologia Polska, 2000, 8, 11–17 (in Polish; English abstract).
• 17. Kosińska K., Drug problems in the elderly. Gerontologia Polska, 2004, 12, 155–159 (in Polish; English abstract).
• 18. Laitinen K., Patronen A., Harju P., Löyttyniemi E., Pylkkänen L., Kleimola T., Perttunen K., Timing and food intake has a marked effect on the bioavailability of clodronate. Bone, 2000, 27, 293–296.
• 19. Lasswell A.B., DeForge B.R., Sobal J., Muncie Jr H.L., Michocki R., Family medicine residents’ knowledge and attitudes about drug-nutrient interactions. J. Am. Coll. Nutr., 1995, 14, 137–143.
• 20. Lewis C.W., Frongillo E.A., Roe D.A., Drug-nutrient interactions in three long-term care facilities. J Am Diet Assoc., 1995, 95, 309–315.
• 21. Lilja J.J., Neuvonen M., Neuvonen P.J., Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin. Br. J. Clin. Pharmacol., 2004, 58, 56–60.
• 22. Magnus M.H., Difficulties in assessing drug/food interactions from chart audit in an elderly Barbadian sample group. J. Nutr. Elder., 1994, 14, 33–43.
• 23. McCabe B.J., Prevention of food-drug interactions with special emphasis on older adults. Curr. Opin. Clin. Nutr. Metab. Care, 2004, 7, 21–26.
• 24. Podlewski J.K., Chwalibogowska-Podlewska A. eds., Leki współczesnej terapii. 1999, Split Trading, Warsaw, pp. 3–776 (in Polish).
• 25. Rajska-Neumann A., Wieczorowska-Tobis K., Polypragmasy in the group of elderly in Poznań. Gerontologia Polska, 2004, 12, 201–204 (in Polish; English abstract).
• 26. Rajska-Neumann A., Wieczorowska-Tobis K., Polypragmasy in the elder patient as a potential risk of drugs interactions-case study. Geriatria Polska, 2006, 2, 80–82 (in Polish; English abstract).
• 27. Schmidt L.E., Dalhoff K., Food – drug interactions. Drugs, 2002, 62, 1481–1502.
• 28. Suliburska J., The assessment of the interaction between hypertension drugs and nutritional constituents and supplements in hypertension patients. Bromat. Chem. Toksykol., 2010, 1, 35–40 (in Polish; English abstract).
• 29. Yonkowski D., Flanders J., Kerestes-Smith J., Ginsberg S., Meeting Joint Commission Standards for Drug/Food Interactions Utilizing Computers and Existing Personnel. J. Am. Diet. Assoc., 1996, 96, 9, Suppl. A81.
• 30. Zhi J., Rakhit A., Patel I.H., Effects of dietary fats on drug absorption. Clin. Pharmacol. Ther., 1995, 58, 487–491.

Uwagi

PL

Rekord w opracowaniu